Literature DB >> 9519649

Failure of prescription prenatal vitamin products to meet USP standards for folic acid dissolution.

S W Hoag1, H Ramachandruni, R F Shangraw.   

Abstract

OBJECTIVE: To determine whether prescription prenatal vitamins meet United States Pharmacopeial Convention (USP) standards for folic acid dissolution.
METHODS: Dissolution was measured using USP Apparatus II and test conditions specified in the 23rd revision of the United States Pharmacopeia (USP 23). Folic acid was assayed by a chromatographic method modified from that specified in the official monographs, for oil- and water-soluble vitamins with minerals tablets, in USP 23.
RESULTS: Only three out of nine multivitamin products met USP specifications for folic acid release. Most missed by a wide margin; folic acid dissolution from two products was less than 25%.
CONCLUSIONS: Because a wide variety of brand-name and generic prescription prenatal multivitamin products were tested, these results are likely to be representative of the multivitamin products on the market. Given the significance of folic acid to public health, the authors believe that this subject should be studied further and that prompt action should be taken to ensure that folic-acid-containing products are of the highest quality possible.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9519649     DOI: 10.1016/s1086-5802(16)30228-5

Source DB:  PubMed          Journal:  J Am Pharm Assoc (Wash)        ISSN: 1086-5802


  3 in total

1.  Folic acid supplementation in early pregnancy and asthma in children aged 6 years.

Authors:  Marit P Martinussen; Kari R Risnes; Geir W Jacobsen; Michael B Bracken
Journal:  Am J Obstet Gynecol       Date:  2011-07-29       Impact factor: 8.661

Review 2.  Bacteria increase host micronutrient availability: mechanisms revealed by studies in C. elegans.

Authors:  Claire Maynard; David Weinkove
Journal:  Genes Nutr       Date:  2020-03-05       Impact factor: 5.523

3.  A bacterial route for folic acid supplementation.

Authors:  Claire Maynard; Ian Cummins; Jacalyn Green; David Weinkove
Journal:  BMC Biol       Date:  2018-06-15       Impact factor: 7.431

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.